Red Light Therapy and Cortisol: What the Skincare Claims Get Right (and Wrong)

Red light devices, from professional in-office panels to LED face masks sold for home use, are marketed for two different things at once: better skin, and lower stress hormones. The skin claims and the cortisol claims rest on very different amounts of evidence, and it is worth separating them before spending money on either.

The underlying mechanism is called photobiomodulation, and it is genuinely established science, not a marketing invention. Red and near-infrared wavelengths of light, roughly in the 600 to 900 nanometer range, penetrate a few millimeters into tissue, where mitochondria, the energy-producing structures inside cells, absorb the light and increase their output of ATP, the cell's basic energy currency. That shift in cellular energy has downstream effects on inflammation, oxidative stress markers, and tissue repair processes, which is the biological basis for every claim that follows.

On the skin side, the evidence is reasonably substantial, if uneven. A 2025 narrative review in the Bratislava Medical Journal analyzed 59 studies covering nearly 1,900 patients and found the strongest evidence for red light in treating acne, with additional support for wound healing and some inflammatory skin conditions. A separate 2025 consensus statement from dermatology researchers, published through the Journal of the American Academy of Dermatology, concluded that photobiomodulation is generally safe but stopped short of standardizing exact protocols, citing wide variation in wavelength, dose, and device quality across studies. The American Academy of Dermatology's own public guidance is similarly measured: it considers at-home red light devices likely safe for short-term use, but notes that the devices dermatologists use in-office are meaningfully more powerful than what is sold for home use, and recommends treating red light as a complement to standard treatment rather than a replacement for it.

The cortisol side of the marketing is much thinner. The proposed mechanism, that photobiomodulation's effect on cellular stress and inflammation could extend to calming the HPA axis and lowering circulating cortisol, is biologically plausible and has been explored in a handful of small human and animal studies. But this line of research is at a far earlier stage than the skin research: sample sizes are small, protocols vary widely, and there is no large, well-controlled trial establishing that a consumer LED mask or panel reliably lowers cortisol in ordinary, healthy adults. That is a meaningfully thinner evidence base than the acne research, even though both claims are attached to the same category of device.

That gap is where marketing language tends to blur two separate questions together: whether red light does something measurable to skin, which has real, if still-maturing, research behind it, and whether it functions as a stress-hormone treatment, which does not currently have that support. A product that plausibly helps with inflammatory acne is not automatically also a validated cortisol-lowering device, even if the same LEDs are doing both jobs in the ad copy.

If you are considering red light therapy, the AAD's practical guidance is a reasonable starting point regardless of which benefit you are after: look for FDA-cleared devices, talk to a dermatologist about realistic expectations for your specific skin concern, and treat any stress- or cortisol-related claims as an unproven bonus rather than the reason to buy the device.